Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1877320
                    [Title] => Hope is on the horizon for novel antidepressants
                    [Summary] => There remains a great unmet need for more effective and rapidly acting treatments for major depressive disorder, and research is revealing that both new and existing drugs may help, according to one expert.
                    [DatePublished] => 2018-12-16 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 1
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 62817
                    [Title] => FDA calls for stronger antidepressant warning
                    [Summary] => 
            
                    [DatePublished] => 2008-05-18 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 33664
                    [Title] => Antidepressants tied to suicide attempts only
                    [Summary] => 
            
                    [DatePublished] => 2007-12-16 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 394542
                    [Title] => FDA scrutinizes antidepressants,risk of suicidality
                    [Summary] => 






Warning may be applied to young adults. Concerns about the risk of suicidality in patients on antidepressant therapy have deepened as a result of a Food and Drug Administration advisory panel’s recommendation to expand a black box warning to include young adults. The proposal also sparked concern, expressed by some of the panelists, that extension of the warning might discourage appropriate antidepressant prescribing.
                    [DatePublished] => 2007-04-15 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

antidepressants

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1877320
                    [Title] => Hope is on the horizon for novel antidepressants
                    [Summary] => There remains a great unmet need for more effective and rapidly acting treatments for major depressive disorder, and research is revealing that both new and existing drugs may help, according to one expert.
                    [DatePublished] => 2018-12-16 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 1
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 62817
                    [Title] => FDA calls for stronger antidepressant warning
                    [Summary] => 
            
                    [DatePublished] => 2008-05-18 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 33664
                    [Title] => Antidepressants tied to suicide attempts only
                    [Summary] => 
            
                    [DatePublished] => 2007-12-16 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 394542
                    [Title] => FDA scrutinizes antidepressants,risk of suicidality
                    [Summary] => 






Warning may be applied to young adults. Concerns about the risk of suicidality in patients on antidepressant therapy have deepened as a result of a Food and Drug Administration advisory panel’s recommendation to expand a black box warning to include young adults. The proposal also sparked concern, expressed by some of the panelists, that extension of the warning might discourage appropriate antidepressant prescribing.
                    [DatePublished] => 2007-04-15 00:00:00
                    [ColumnID] => 136231
                    [Focus] => 0
                    [AuthorID] => 1805110
                    [AuthorName] => Charles C. Chante MD
                    [SectionName] => Opinion
                    [SectionUrl] => opinion
                    [URL] => 
                )

        )

)

abtest

Hope is on the horizon for novel antidepressants

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | December 16, 2018 - 12:00am

There remains a great unmet need for more effective and rapidly acting treatments for major depressive disorder, and research is revealing that both new and existing drugs may help, according to one expert.

Opinion

FDA calls for stronger antidepressant warning

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | May 18, 2008 - 12:00am

Opinion

Antidepressants tied to suicide attempts only

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | December 16, 2007 - 12:00am

Opinion

FDA scrutinizes antidepressants,risk of suicidality

By YOUR DOSE OF MEDICINE | By Charles C. Chante MD | April 15, 2007 - 12:00am

Warning may be applied to young adults. Concerns about the risk of suicidality in patients on antidepressant therapy have deepened as a result of a Food and Drug Administration advisory panel’s...

Opinion